Scope of the Study
Nanomedicine is treatment of diseases, injuries or pain by usage of molecular tools. It is made by application of nano technology and used for the prevention of diseases. The size of nanomaterial is similar to biological molecules and can easily target the difficult to reach sites. It can provide same results in smaller dose as conventional counterparts. Additionally, the decreased size causes the surface area to volume ratio to rise which is suitable for the chemical interaction with biomolecules. There is wide applications of nanomedicine in medical diagnostics
The market study is being classified by Type (Liposomes, Micelles, Nanocrystals, Polymeric Nanoparticles, Metallic Nanoparticles, Mesoporous Silica Nanoparticles and Others), by Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Implants and Others) and major geographies with country level break-up.
GE Healthcare (United States), Johnson & Johnson (United States), Mallinckrodt plc (United Kingdom), Merck & Co. Inc. (United States), Nanosphere Inc. (United States), Pfizer Inc. (United States), Teva Pharmaceutical Industries Ltd. (Israel), UCB (Union chimique belge) S.A (Belgium), Nanobiotix (France) and Nanomedical systems (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sigma-Tau Pharmaceuticals Inc. (United Kingdom), Smith & Nephew PLC (United Kingdom) and Stryker Corp (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nanomedicine market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Nanomedicine market by Type, Application and Region.
On the basis of geography, the market of Nanomedicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Usage of Injectable Nano Medicine
- Growing Need of Therapies with Lesser Side Effects
- Increasing Adoption of Nanomedicine in Multiple Applications
- Introduction of Innovative Technologies for Drug Deliveries
- Increasing Availability of Generics in Developing and Developed Countries
- Long Approvals Associated with the Nanomedicien
- Rising Initiatives by Government for Health Care
Market Leaders and their expansionary development strategies
In 2019, Johnson and Johnson has acquired Auris Health Inc which will help to solve the unmet clinical needs
Key Target AudienceManufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase